Across rheumatic diseases

Dimerization as a key feature of autoreactive immunoglobulin A (IgA) antibody responses

Ann Rheum DisPublished Mechanistic study

Authors' conclusion

These findings indicate that dimeric (autoreactive) IgA responses are associated with newly emerging antigen-specific immune activation, where production temporarily shifts to dimeric IgA. Mucosal triggering is not necessarily always involved in these IgA immune responses.

Study context

Population
Plasma of patients with RA, SSc, AAV, SLE, SARS-CoV-2 vaccinated healthy individuals and healthy controls
Comparison
Dimeric proportion of autoreactive IgA vs total IgA in rheumatic autoimmune diseases, and of anti-spike IgA after SARS-CoV-2 vaccination
Outcome
Proportion of dimeric IgA, autoantibodies vs total IgA
Methodological detailssize exclusion chromatography, ELISA on size exclusion chromatography (SEC) fractions, confirmed by western blot and tandem mass spectrometry
  • Size exclusion chromatography
  • ELISA on SEC fractions
  • Confirmed by western blot and tandem mass spectrometry

Main finding

As reported in the abstract

RA, AAV and SLE: dimeric autoreactive IgA vs total IgA

≈ 60%-80% vs total IgA ≈ 20%

SLE total IgA dimeric

≈ 60%

Original publication

Dimerization as a key feature of autoreactive IgA antibody responses. Ann Rheum Dis. Published 29 November 2025. doi:10.1016/j.ard.2025.11.003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.